ATE205847T1 - 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-one derivate antagonisten der rezeptoren ampa und nmda, ihre herstellung und zwischenprodukte und sie enthaltende arzneimittel - Google Patents

5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-one derivate antagonisten der rezeptoren ampa und nmda, ihre herstellung und zwischenprodukte und sie enthaltende arzneimittel

Info

Publication number
ATE205847T1
ATE205847T1 AT97900236T AT97900236T ATE205847T1 AT E205847 T1 ATE205847 T1 AT E205847T1 AT 97900236 T AT97900236 T AT 97900236T AT 97900236 T AT97900236 T AT 97900236T AT E205847 T1 ATE205847 T1 AT E205847T1
Authority
AT
Austria
Prior art keywords
indeno
nmda
imidazo
pyrazine
production
Prior art date
Application number
AT97900236T
Other languages
English (en)
Inventor
Jean-Claude Aloup
Jean Bouquerel
Dominique Damour
Jean-Claude Hardy
Patrick Jimonet
Franco Manfre
Serge Mignani
Patrick Nemecek
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE205847T1 publication Critical patent/ATE205847T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT97900236T 1996-01-10 1997-01-06 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-one derivate antagonisten der rezeptoren ampa und nmda, ihre herstellung und zwischenprodukte und sie enthaltende arzneimittel ATE205847T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9600192A FR2743366B1 (fr) 1996-01-10 1996-01-10 Derives de 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-4-one, leur preparation, leurs intermediaires et les medicaments les contenant
PCT/FR1997/000019 WO1997025328A1 (fr) 1996-01-10 1997-01-06 DERIVES DE 5H,10H-IMIDAZO(1,2-a)INDENO(1,2-e)PYRAZINE-4-ONE, LEUR PREPARATION, LEURS INTERMEDIAIRES ET LES MEDICAMENTS LES CONTENANT______________________________________________________________

Publications (1)

Publication Number Publication Date
ATE205847T1 true ATE205847T1 (de) 2001-10-15

Family

ID=9487995

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97900236T ATE205847T1 (de) 1996-01-10 1997-01-06 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-one derivate antagonisten der rezeptoren ampa und nmda, ihre herstellung und zwischenprodukte und sie enthaltende arzneimittel

Country Status (20)

Country Link
US (2) US5990108A (de)
EP (1) EP0880522B1 (de)
JP (1) JP2000505073A (de)
KR (1) KR19990077135A (de)
AR (1) AR005424A1 (de)
AT (1) ATE205847T1 (de)
AU (1) AU1383097A (de)
BG (1) BG102618A (de)
CA (1) CA2239254A1 (de)
CZ (1) CZ216698A3 (de)
DE (1) DE69706830T2 (de)
DK (1) DK0880522T3 (de)
ES (1) ES2164323T3 (de)
FR (1) FR2743366B1 (de)
MX (1) MX9805167A (de)
PL (1) PL327942A1 (de)
PT (1) PT880522E (de)
SK (1) SK93498A3 (de)
WO (1) WO1997025328A1 (de)
ZA (1) ZA9786B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999047497A2 (en) * 1998-03-13 1999-09-23 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
US6242493B1 (en) 1998-03-13 2001-06-05 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
WO2003029210A2 (en) * 2001-10-04 2003-04-10 Merck & Co. Inc. Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
US6951944B2 (en) * 2002-02-21 2005-10-04 Azwell Inc. Production of imidazole derivatives and novel intermediates of the derivatives
GB0415320D0 (en) * 2004-07-08 2004-08-11 Astrazeneca Ab Novel compounds
US7649098B2 (en) * 2006-02-24 2010-01-19 Lexicon Pharmaceuticals, Inc. Imidazole-based compounds, compositions comprising them and methods of their use
TW200920355A (en) * 2007-09-06 2009-05-16 Lexicon Pharmaceuticals Inc Compositions and methods for treating immunological and inflammatory diseases and disorders
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
JP7305560B2 (ja) 2017-06-12 2023-07-10 グリテック, エルエルシー Nmdaアンタゴニスト及びd2/5ht2a又は選択的5ht2aアンタゴニストによるうつ病の治療

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2717812B1 (fr) * 1994-03-28 1996-05-10 Rhone Poulenc Rorer Sa Indeno[1,2-e]pyrazine-4-ones, leur préparation et les médicaments les contenant.
FR2732681B1 (fr) * 1995-04-05 1997-07-04 Rhone Poulenc Rorer Sa Derives de 10h-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-one, leur preparation et les medicaments les contenant

Also Published As

Publication number Publication date
EP0880522A1 (de) 1998-12-02
MX9805167A (es) 1998-10-31
ZA9786B (en) 1997-07-17
KR19990077135A (ko) 1999-10-25
FR2743366B1 (fr) 1998-02-06
DK0880522T3 (da) 2002-01-21
AR005424A1 (es) 1999-06-23
BG102618A (en) 1999-09-30
AU1383097A (en) 1997-08-01
US5990108A (en) 1999-11-23
SK93498A3 (en) 1998-12-02
PT880522E (pt) 2002-05-31
WO1997025328A1 (fr) 1997-07-17
EP0880522B1 (de) 2001-09-19
DE69706830D1 (de) 2001-10-25
CZ216698A3 (cs) 1998-10-14
PL327942A1 (en) 1999-01-04
ES2164323T3 (es) 2002-02-16
JP2000505073A (ja) 2000-04-25
US6100264A (en) 2000-08-08
DE69706830T2 (de) 2002-04-25
CA2239254A1 (fr) 1997-07-17
FR2743366A1 (fr) 1997-07-11

Similar Documents

Publication Publication Date Title
EP0442878A4 (en) Derivatives of tryptophan as cck antagonists
DE59808281D1 (de) Disubstituierte bicyclische heterocyclen, ihre herstellung und ihre verwendung als arzneimittel
ATE14725T1 (de) Neue benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel.
DE69622183D1 (de) Chinolinderivate und chinazolinderivate welche die autophosphorylierung des von blutplättchen abstammenden wachstumsfaktorrezeptors inhibiren und sie enthaltende pharmazeutische zusammensetzungen
PL326083A1 (en) Novel pyrimidin derivatives as antagonists of 5ht 2c receptor
HUP9701596A3 (en) 2,4-diamino-1,3,5-triazine derivatives, process for their preparation, their use for the preparation of pharmaceutical compositions and the pharmaceutical compositions containing them
AR002039A1 (es) Pirido[3.2-e]pirazinonas con efecto antiasmatico, y procedimiento para su preparacion y los medicamentos que los contienen y su preparación
DE69715009D1 (de) Substituierte thiazolidinedione derivate, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten
EP0707581A1 (de) Indolin derivate als 5 ht2c antagonisten
AU3461293A (en) Benzodiazepine derivatives, as CCK and gastrin antagonists
HUP9702509A3 (en) Derivatives of fused heterocycles substituted on the aminogroup, process for producing them, their use and pharmaceutical compositions thereof
ATE205847T1 (de) 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-one derivate antagonisten der rezeptoren ampa und nmda, ihre herstellung und zwischenprodukte und sie enthaltende arzneimittel
ZA93821B (en) New derivatives of baccatin III and of 10-deacetyibaccatin III, their preparation and the pharmaceutical compositions which contain them.
FI951555L (fi) 5H,10H-imidatso[1,2-a]indeno[1,2-e]pyratsin-4-onijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet
AU6143694A (en) Use of 2h-1,2,4-benzothiadiazine 3(4h)-one 1,1 dioxide derivatives as non-competitive nmda receptor antagonists
ATA269688A (de) Neue alkoxyderivate der ginkgolide, ihre herstellung und sie enthaltende therapeutische zusammensetzungen
HUP9800631A3 (en) 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions
DE69517768D1 (de) IMIDAZOLYLALKYLDERIVATE VON IMIDAZO [5,1-c][1,4]BENZOXAZIN-1-ON UND IHRE VERWENDUNG ALS ARZNEIMITTEL
NO953050D0 (no) Anvendelse av neurotensin-antagonister for fremstilling av diuretiske medikamenter
ATE207923T1 (de) 5h, 10h-imidazo (1,2-a) indeno (1,2-e) pyrazin -4-one derivate ihre herstellung und diese enthaltende arzneimittel
IL95409A0 (en) Substituted n-heterocyclic five-membered ring derivatives,their preparation and pharmaceutical compositions containing them
ZA914376B (en) Benzimidazole derivatives,their preparation process,the intermediates obtained,their use as medicaments and the pharmaceutical compositions containing them
FI940607A7 (fi) Imidatso(5,1-C)(1,4)bentsoksatsin-1-onijohdannaiset 5HT3-antagonisteina
IL95408A0 (en) Substituted heterocyclic fivemembered ring derivatives,their preparation and pharmaceutical compositions containing them
FI965186A0 (fi) 1,2,5,6-Tetrahydropyridiinijohdannaisten käyttö rauhoittavien lääkkeide valmistamiseksi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee